Learning from the past: four pillars of clinical trial design
Although existing problems in clinical trial design have been intensified by COVID-19, the pandemic was not the root cause of these issues. Many trials are at risk due to design issues, resulting in costly protocol amendments and delays. At Phesi, we take a four pillars approach that lets sponsors tackle long-standing problems in trial design.
Site effectiveness index: a strategically important metric in clinical trial planning
The importance of site activation planning and implementation is a given among those who develop and manage clinical trials.
Site, investigator, or investigator site?
The life sciences industry is riddled with casually used terms, acronyms and phrases which are often used out of context or defined differently among companies or individuals.